ORYZON Publishes Vafidemstat First-in-Human Clinical Trial Manuscript in CNS Drugs Journal
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers Paper confirms vafidemstat…
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers Paper confirms vafidemstat…
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX…
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Mandarin session on April 7, 2021 and English session on April 26, 2021 for investors…
SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
GARDEN CITY, N.Y., March 24, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical…
Regulatory success achieved in Japan by partner Teijin Pharma Limited Ostabaro® approved for treatment of…
Hamilton, Bermuda, March 24, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company…
MONTREAL, March 24, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a…
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) — Today Abcam (AIM:ABC; NASDAQ:ABCM), a global…
Kolab Project 232 Series Diamonds High-potency Kolab Project 232 Series Diamonds. Kolab Project 232 Series…
QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity…
Webcast and conference call to take place on Tuesday, March 30, 2021 at 4:30 p.m….
MOUNTAIN VIEW, Calif., March 24, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage…
BOTHELL, Wash., March 24, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late…
– Initial data from Cohort 1 of the PEARL-1 study shows safety and tolerability of…
Data readout of Phase 1b trial of CVL-231 in patients with schizophrenia now expected mid-year…
78.4% of women who continued on relugolix combination therapy remained responders (menstrual blood loss <…
PRINCE EDWARD COUNTY, Ontario, March 24, 2021 (GLOBE NEWSWIRE) — Prince Edward County-based software development…